Corneal Ectasia

• FDA approval · 2025-10-17
  FDA Approved: EPIOXA CROSS-LINKING — Original Application (Glaukos Corporation)

  The FDA approved the original application for EPIOXA CROSS-LINKING (riboflavin 5-phosphate ophthalmic) by Glaukos Corporation for use in cor…

• FDA approval · 2025-02-07
  FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)

  FDA approved a supplemental application for Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) from Glaukos Corporation.

• FDA approval · 2019-01-25
  FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)

  The FDA approved a supplemental application for the Photrexa Cross-Linking Kit, including riboflavin 5-phosphate ophthalmic solution, used t…

• FDA approval · 2018-10-29
  FDA Approved: PHOTREXA CROSS-LINKING KIT — Supplemental Application (Glaukos Corporation)

  FDA approved a supplemental application for the Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) by Glaukos Corporation, suppo…

• FDA approval · 2016-04-15
  FDA Approved: PHOTREXA CROSS-LINKING KIT — Original Application (Glaukos Corporation)

  FDA approved Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) from Glaukos for corneal collagen cross-linking to slow progress…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.